Áttétes emlőrák: nyitott vizsgálatok itt: Mexikó

13 nyitott vizsgálatnak van helyszíne itt: Mexikó. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT06790693
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Kísérleti kezelés · 3. fázis · Hoffmann-La Roche
Centro Estatal de Cancerologia de Chihuahua, Chihuahua City · Centro de Investigacion y Tratamiento Integral del Cancer: CITI Cancer Oaxaca S.A de C.V., Ciudad de Huajuapan de León · Iem-Fucam, D.F. · Instituto Nacional de Cancerologia, Distrito Federal · Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara · Hospital General de Mexico, MexicoCiudad de México · Hospital Zambrano Hellion TecSalud, Monterrey · Centro de Investigacion Clinica de Oaxaca, Oaxaca City
Regiszter frissítve: 2026-11-04
NCT07060807
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC
Unidad de Mastologia Avanzada de Chihuahua S.A de C.V (Site 0602), Chihuahua City · CIO - Centro de Inmuno-Oncología de Occidente (Site 0600), Guadalajara · Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" (Site 0604), Monterrey · Centro de Investigacion Clinica de Oaxaca (Site 0601), Oaxaca City · Cuidados Oncologicos. (Site 0605), Querétaro City
Regiszter frissítve: 2026-11-03
NCT07368998
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
Kísérleti kezelés · 2. fázis · Hoffmann-La Roche
Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara · Renati Innovation S.A.P.I. DE C.V., Guadalajara · CENEIT Oncologicos, Mexico City · Centro de Infusion Tratamiento e Investigacion Oncologica S DE R, Queretaro Qro
Regiszter frissítve: 2026-11-03
NCT07405801
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Kísérleti kezelés · 2. fázis · Hoffmann-La Roche
Instituto Nacional de Cancerologia, Distrito Federal · Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara · Centro de Investigacion Clinica de Oaxaca, Oaxaca City
Regiszter frissítve: 2026-11-03
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Kísérleti kezelés · 1/2. fázis · Pfizer
INCAN, Mexico City · Hospital MAC Periferico Sur, Mexico City · COI Centro Oncologico Internacional S.A.P.I. de C.V., Mexico City · Hospital Universitario Dr. Jose Eleuterio González, Monterrey · Hospital Reforma, Oaxaca City · Oaxaca Site Management Organization, Oaxaca City
Regiszter frissítve: 2026-10-28
NCT05646862
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Kísérleti kezelés · 3. fázis · Hoffmann-La Roche
Instituto Nacional de Cancerologia, Distrito Federal · Panamerican Clinical Research S.A. de C.V, Guadalajara · Renati Innovation S.A.P.I. DE C.V., Guadalajara · ARKE Estudios Clínicos S.A. de C.V., Mexico City · CENEIT Oncologicos, Mexico City · Health Pharma Professional Research, Mexico City · OncoMed, Mexico City · COI Centro Oncologico Internacional Santa Fe, Mexico City · Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Morelia
Regiszter frissítve: 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Kísérleti kezelés · 1/2. fázis · Daiichi Sankyo
Medical Care & Research Sa de Cv, Mérida · Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida · Cryptex Investigacion Clinica S.A. de C.V., México
Regiszter frissítve: 2026-10-26
NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Kísérleti kezelés · 3. fázis · Pfizer
Sitio Clínico UIS Chihuahua, Chihuahua City · COI Centro Oncologico Internacional S.A.P.I. de C.V., Mexico City · Centro de Investigacion Clinica de Oaxaca, Oaxaca City · Fundación Santos y de la Garza Evia I.B.P, San Pedro Garza García · coi Centro Oncologico Internacional sapi de cv, Tlajomulco de Zúñiga
Regiszter frissítve: 2026-10-19
NCT05894239
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Kísérleti kezelés · 3. fázis · Hoffmann-La Roche
Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara · Centro Oncológico Hematológico Roma, Mexico City · OncoMed, Mexico City · CENEIT Oncologicos, Mexico City · Hospital Universitario, Monterrey
Regiszter frissítve: 2026-10-16
NCT06312176
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC
CIO - Centro de Inmuno-Oncología de Occidente (Site 0592), Guadalajara · Health Pharma Professional Research S.A. de C.V: (Site 0598), Mexico City · Grupo Médico ASSET-Clinical Research (Site 0596), Mexico City · INCAN-TUMORES MAMARIOS (Site 0597), Mexico City · Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología (Site 0590), Monterrey · CENTRO MEDICO ZAMBRANO HELLION-Centro de Cáncer de Mama (Site 0595), San Pedro Garza García
Regiszter frissítve: 2026-10-13
NCT06757634
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Kísérleti kezelés · 3. fázis · Celcuity Inc
San Peregrino Unidad de Investigacion, Aguascalientes · Office of Emanuel de la Mora Jimenez, MD/equiv, Guadalajara · Centro de Atención Oncológica Viva, Mexico City · Clinical Research Center Chapultepec Mexico City, Mexico City · Avix Clinical Research, Monterrey · Filios High Medicine, Monterrey · Administrative Society of Health Services, SC, Morelia
Regiszter frissítve: 2026-10-09
NCT07225309
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Kísérleti kezelés · Memorial Sloan Kettering Cancer Center
Instituto Nacional de Cancerología (INCan), Mexico City
Regiszter frissítve: 2026-08-03
NCT05544240
Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors
Kísérleti kezelés · 1. fázis · Williams Cancer Foundation
Hospital Diomed, Mexico City
Regiszter frissítve: 2025-04-06

Minden vizsgálat (Áttétes emlőrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek